Menu Back toSession-0705-Detection-and-Evaluation-of-Immunogenicity-of-Biologics
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
The 7th DIA China Annual Meeting
Session 0705 Detection and Evaluation of Immunogenicity of Biologics
- Academy of Military Medical Sciences, China
Recommendations from the AAPS LBABFG Biosimilars Action Program Committee on the Development and Validation of ADA assays for Biosimilars
- President and Chief Scientific Officer
- Biologics Development Services, LLC, USA, China
- Group Manager/CNIBR DMPK-Biologics
- Novartis, China
Important Consideration in Anti-drug Antibody Assay Development
- Senior Director, Bioanalytical services
- Wuxi AppTec, China